Metabolic and hepatic effects of bloodletting in dysmetabolic iron overload syndrome: A randomized controlled study in 274 patients

Mechanisms Linking Glucose Homeostasis and Iron Metabolism Toward the Onset and Progression of Type 2 Diabetes

(2015) José Manuel Fernández-Real et al.   DIABETES CARE

Does the death knell toll for phlebotomy in NAFLD?

(2015) John D. Ryan et al.   HEPATOLOGY

The impact of phlebotomy in nonalcoholic fatty liver disease: A prospective, randomized, controlled trial

(2015) Leon A. Adams et al.   HEPATOLOGY

Both Hepatic and Body Iron Stores Are Increased in Dysmetabolic Iron Overload Syndrome. A Case-Control Study

(2015) Caroline Jézéquel et al.   PLoS One

A randomized trial of iron depletion in patients with nonalcoholic fatty liver disease and hyperferritinemia

(2014) Luca Valenti   WORLD JOURNAL OF GASTROENTEROLOGY

Phase II clinical trial of phlebotomy for non-alcoholic fatty liver disease

(2013) M. D. Beaton et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 Diabetes

(2013) Andreas L. Birkenfeld et al.   HEPATOLOGY

Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease

(2010) S. McPherson et al.   GUT

Predicting Diabetes: Clinical, Biological, and Genetic Approaches: Data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR)

(2008) B. Balkau et al.   DIABETES CARE